Skip to main content
OpenTrials
Completed

NCT Number: NCT07749690

Mental Rotation and Motor Imagery Training in Multiple Sclerosis

This randomized controlled trial investigated the effects of sequential laterality, motor imagery, and mental rotation training in individuals with relapsing-remitting multiple sclerosis. Both groups received conventional physiotherapy, while the intervention group received structured cognitive-motor training and the control group received active visual-attention training.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Abant Izzet Baysal University Faculty of Health Science

Bolu, 14100, Turkey (Türkiye)

About this study

Fifty-four participants were randomly assigned to the intervention or control group. Both groups received 45-minute sessions three times per week for six weeks. Mental rotation ability was the primary outcome, while upper-extremity function, manual ability, motor imagery, grip strength, dexterity, and information-processing speed were assessed as secondary outcomes. Assessments were performed before and after the intervention by a researcher blinded to group allocation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with definite relapsing-remitting multiple sclerosis by a neurologist according to the revised McDonald criteria
  • Not experiencing an acute MS relapse
  • Mini Mental State Examination score ≥24
  • No clinical MS relapse within the previous 3 months
  • No corticosteroid treatment for an MS relapse within the previous 3 months
  • Expanded Disability Status Scale score between 1.5 and 6.0
  • Modified Ashworth Scale score ≤2
  • Sufficient communication ability to understand visual and verbal instructions and follow the training protocol
  • Able to attend at least 80% of the planned sessions
  • Able to complete the Movement Imagery Questionnaire-3

Exclusion criteria

  • Any medication change within the previous 3 months
  • Uncorrected severe visual or hearing impairment
  • A communication disorder preventing the perception of or response to the visual and verbal stimuli used in the study
  • Participation in another structured upper-extremity rehabilitation program or interventional study during the study period
  • Presence of an additional neurological disorder
  • Advanced sensory loss or proprioceptive impairment that could affect participation in the intervention
  • Botulinum toxin injection within the previous 3 months

Treatment and study plan

Laterality, Motor Imagery, and Mental Rotation Training

Other

Participants received 30 minutes of conventional physiotherapy followed by 15 minutes of structured training, three times per week for six weeks. The training progressed sequentially through laterality recognition, motor imagery, and mental rotation. Laterality training involved identifying right- and left-hand images. Motor imagery training involved imagining the hand positions and movements shown in the images without performing an observable movement. Mental rotation training involved mentally rotating figures and selecting the correct response.

Active Visual-Attention Control Training

Other

Participants received 30 minutes of conventional physiotherapy followed by 15 minutes of active visual-attention control training, three times per week for six weeks. The training included images of neutral objects, colors, geometric shapes, and symbols that did not depict body parts. Participants classified the images according to color, shape, size, position, or similarity and difference.

Primary outcomes

  1. The Purdue Spatial Visualization Test

    Time frame: Baseline and immediately after the 6-week intervention.

    The Purdue Spatial Visualization Test a widely used mental rotation tests, consists of 30 three-dimensional spatial perception questions.

Secondary outcomes

  1. The Symbol Digit Modalities Test

    Time frame: Baseline and immediately after the 6-week intervention.

    The Symbol Digit Modalities Test is a widely used assessment tool for measuring information-processing speed in patients with MS.

  2. Nine-Hole Peg Test

    Time frame: Baseline and immediately after the 6-week intervention.

    In the Nine-Hole Peg Test, nine wooden pegs were placed into a wooden board containing nine holes using one hand.

  3. Kinesthetic and Visual Imagery Questionnaire

    Time frame: Baseline and immediately after the 6-week intervention.

    Motor imagery ability was evaluated and scored using 20 items examining movements of different body parts in a sitting position, with two subscales assessing kinesthetic and visual imagery abilities. The total score ranges from 10 to 50, with each subscale ranging from 5 to 25.

  4. Grip Strength

    Time frame: Baseline and immediately after the 6-week intervention

    Grip strength was assessed using a Jamar hand dynamometer.

  5. Abilhand

    Time frame: Baseline and immediately after the 6-week intervention.

    Abilhand is a patient-reported scale used to determine the perceived level of difficulty individuals experience when using their hands during activities of daily living. The Abilhand total raw score ranges from 0 to 46, with higher scores indicating better self-perceived manual ability in performing daily bimanual activities.

  6. The Action Research Arm Test (ARAT)

    Time frame: Baseline and immediately after the 6-week intervention.

    The Action Research Arm Test was used to evaluate upper extremity functional capacity and consists of four subdomains: grasp, grip, pinch, and gross movement.

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Abant Izzet Baysal University

Other

Registry information

Official study title

Mental Rotation and Motor Imagery Training for Upper-Extremity Function in Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Aug 6, 2026
Registry last updated
Aug 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.